Tylan 200 200 mg Solution is a Health Canada–registered veterinary drug (DIN 00103594) held by Elanco Canada Limited, containing Tylosin. Health Canada lists its status as Dormant (status date 30 Jul 2026). Nexara Health has matched 24 registrations of Tylosin across 4 other regulated markets.
Health Canada registration
| DIN | 00103594 |
|---|---|
| Brand name | Tylan 200 |
| Active ingredient | Tylosin |
| Strength | 200 mg |
| Dosage form | Solution |
| Route | Intramuscular |
| Company | Elanco Canada Limited |
| Status | Dormant — 30 Jul 2026 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Status and company history
Changes Health Canada has recorded for this DIN, as observed by Nexara Health's weekly DPD comparison.
| Date | Field | From | To |
|---|---|---|---|
| 2026-09-03 | Status | Marketed | Dormant |
| 2026-09-03 | Status | Marketed | Dormant |
Tylosin registered in other markets
24 registrations of the same molecule in 4 national registries outside Canada (first 21 shown, exact strength and form first). Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| Denmark | Tilsing Vet. | Dopharma Research B.V. | 200.000 IE/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Tylan Vet. | Elanco GmbH | 200 mg/ml | injektionsvæske, opløsning | National | Laegemiddelstyrelsen |
| Denmark | Tylmasin | Huvepharma NV | 200 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Tylovet | Biovet J.S.C. | 200 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Denmark | Tylucyl | Vetoquinol Scandinavia AB | 200 mg/ml | injektionsvæske, opløsning | Decentral procedure | Laegemiddelstyrelsen |
| Malaysia | INECTIL 20% Injectable solution | Laboratorios Reveex (asia) Sdn. Bhd. | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Tylan 200 mg/ml Injection | Elanco Malaysia Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Malaysia | Vime Tylovet 50 mg/ml Solution for Injection | Vemedim Sdn Bhd | Veterinary | PRODUCT APPROVED | NPRA | |
| Poland | Biotyl 200 | Biowet Drwalew Sp. z o.o. | 20 g / 100 ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Biotyl 50 | Biowet Drwalew Sp. z o.o. | 5 g / 100 ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Dophatyl-ject | Dopharma Research B.V. | 200000 j.m./ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Pharmasin | Huvepharma NV | 200 mg/ml | Roztwór do wstrzykiwań | Bezterminowe | URPL RPL |
| Poland | Pharmasin | Huvepharma NV | 250 000 IU | Granulat doustny | Bezterminowe | URPL RPL |
| Poland | Tilsol | Ceva Salute Animale S.p.A. | 200 g/1000 g | Proszek do sporządzania roztworu doustnego | Bezterminowe | URPL RPL |
| Poland | Tylan G 100 Premix | Elanco GmbH | 100 g/1 kg | Premiks do sporządzania paszy leczniczej | Bezterminowe | URPL RPL |
| Poland | Tylan Soluble Powder | Elanco GmbH | 1000 g/ 1 kg | Proszek do sporządzania roztworu doustnego | 2026-10-10 | URPL RPL |
| United States | tylosin | Shandong Lukang Shelile Pharmaceutical Co.,Ltd | Powder | FDA NDC | ||
| United States | tylosin phosphate | Shandong Lukang Shelile Pharmaceutical Co.,Ltd | Powder | FDA NDC | ||
| United States | Tylosin tartrate | Shandong Lukang Shelile Pharmaceutical Co., Ltd. | Powder | FDA NDC | ||
| United States | Tylosin Tartrate | Ningxia Taiyicin Biotech Co., Ltd. | Powder | FDA NDC | ||
| United States | Tylosin Tartrate | Medisca Inc. | Powder | FDA NDC |
See every manufacturer of Tylosin worldwide →
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. This DIN is not currently marketed in Canada. The registrations above show which regulated markets hold an equivalent presentation that can be sourced for clinical comparator use or on a named-patient basis under Health Canada's Special Access Programme. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Tylan 200 (DIN 00103594) marketed in Canada?
No. Health Canada lists DIN 00103594 as Dormant as of 30 Jul 2026.
Who holds the Canadian licence for this product?
Elanco Canada Limited is the company of record in the Health Canada Drug Product Database.
Is Tylosin registered outside Canada?
Yes — Nexara Health has matched 24 registrations in 4 other markets (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 00103594, status date 2026-07-30; national medicine registries: FDA NDC, Laegemiddelstyrelsen, NPRA, URPL RPL. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 00103594, status date 2026-07-30; national medicine registries: FDA NDC, Laegemiddelstyrelsen, NPRA, URPL RPL.
Health Canada Drug Product Database (DPD), DIN 00103594, status date 2026-07-30; national medicine registries: FDA NDC, Laegemiddelstyrelsen, NPRA, URPL RPL. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.